Patient risk profiles for progression of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

被引:8
|
作者
Lowe, FC [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, New York, NY 10019 USA
关键词
lower urinary tract symptoms; benign prostatic hyperplasia; disease progression; acute urinary retention; surgery; risk factors;
D O I
10.1016/j.eursup.2004.08.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lower urinary tract symptoms suggestive of benign prostatic disease (LUTS/BPH) wax and wane over time but overall there is a slow worsening of symptoms in the long term. Although the majority of patients progress due to symptomatic worsening, some patients are also at risk of developing acute urinary retention (AUR) and/or will need prostatic surgery. In the day-to-day management of LUTS/BPH patients, it is important to know which patients will progress and/or which factors/clinical variables can predict which progression. This is necessary in order to determine "who to treat and how to treat". This review article on risk factors/clinical variables indicates that for the overall risk of disease progression, a high post-void residual (PVR) and low maximum flow rate (Q(max); factors believed to be predictive for obstruction) are the most important risk factors followed by severe symptoms and a large prostate volume/high prostate specific antigen (PSA). A large prostate volume/high PSA (factors believed to be associated with prostate growth) are most predictive for the occurrence of AUR. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [21] Achieving the total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management
    O'Leary, M
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 25 - 33
  • [22] LUTS in BPH Patients Silodosin for the Treatment of lower Urinary Tract Symptoms in Men with benign Prostatic Hyperplasia
    Praus, F.
    Miernik, A.
    UROLOGE, 2019, 58 (07): : 795 - 798
  • [23] Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
    Cavanaugh, Dana
    Urbanucci, Alfonso
    Mohamed, Nihal E.
    Tewari, Ashutosh K.
    Figueiro, Mariana
    Kyprianou, Natasha
    PROSTATE, 2024, 84 (05): : 417 - 425
  • [24] Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression
    Berges, R
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 19 - 24
  • [25] Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion
    Lowe, FC
    Batista, J
    Berges, R
    Chartier-Kastler, E
    Conti, G
    Desgrandchamps, F
    Dreikorn, K
    O'Leary, M
    Perez, M
    Speakman, M
    Trachtenberg, J
    Tubaro, A
    Meesen, B
    Smets, L
    Stoevelaar, H
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (03) : 206 - 209
  • [26] Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion
    F C Lowe
    J Batista
    R Berges
    E Chartier-Kastler
    G Conti
    F Desgrandchamps
    K Dreikorn
    M O'Leary
    M Perez
    M Speakman
    J Trachtenberg
    A Tubaro
    B Meesen
    L Smets
    H Stoevelaar
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 206 - 209
  • [27] The oral controlled absorption system (OCAS®):: The evolution of tamsulosin for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Chapple, CR
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) : 20 - 22
  • [28] Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction
    Brock, Gerald
    Broderick, Gregory
    Roehrborn, Claus G.
    Xu, Lei
    Wong, David
    Viktrup, Lars
    BJU INTERNATIONAL, 2013, 112 (07) : 990 - 997
  • [29] The total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management: Introduction and conclusions
    Chapple, CR
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 1 - 5
  • [30] Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile
    Crawford, ED
    BJU INTERNATIONAL, 2005, 95 : 1 - 5